Modulation of Antigen Expression in Human Tumor Cell Populations

References

• Klein G. Tumor-specific transplantation antigens. G.H.A. Clowes Memorial Lecture. Cancer Res 1968; 28: 625–635
   PubMed Web of Science ®Google Scholar
• Old LJ. Cancer immunology: The search for specificity. G.H.A. Clowes Memorial Lecture. Cancer Res 1981; 41: 361–375
   PubMed Web of Science ®Google Scholar
• Kohler M, Milstein C. Continuous cultures of fused cells secreting antibody of pre-defined specificity. Nature 1975; 256: 295–497
   Google Scholar
• Taylor-Papadimitriou J, Peterson JA, Arklie J. Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: Production and reaction with cells in culture. Int J Cancer 1981; 28: 17–21
   PubMed Web of Science ®Google Scholar
• Arklie J, Taylor-Papadimitriou J, Bodmer W. Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers. Int J Cancer 1981; 28: 23–29
   PubMed Web of Science ®Google Scholar
• Foster CS, Dinsdale EA, Edwards PAW. Monoclonal antibodies to the human mammary gland: n. Distribution of determinants in breast carcinomas. Virch Arch [Pathol Anat] 1982; 394: 295–305
   PubMed Web of Science ®Google Scholar
• Rasmussen BB, Milkens J, Hilgers J. Monoclonal antibodies applied to primary human breast carcinoma: Relationship to menopausal status, lymph node status, and steroid hormone receptor content. Breast Cancer Res Treat 1982; 2: 401–405
   Google Scholar
• Menard S, Tagliabue E, Canevari S. Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. Cancer Res 1983; 43: 1295–1300
   PubMed Web of Science ®Google Scholar
• Canevari S, Fossati G, Balsari A. Immunohistochemical analysis of the determinant recognized by monoclonal antibody MBrl which specifically binds to human mammary epithelial cells. Cancer Res 1983; 43: 1301–1305
   PubMed Web of Science ®Google Scholar
• Thompson CH, Jones SL, Whitehead RH. A human breast tissue-associated antigen detected by a monoclonal antibody. J Natl Cancer Inst 1983; 70: 409–417
   PubMed Web of Science ®Google Scholar
• Papsidero LD, Croghan GA, O'Connell MJ. Monoclonal antibodies (F36/22 and M7/105) to human breast carcinoma. Cancer Res 1983; 43: 1741–1747
   PubMed Web of Science ®Google Scholar
• Croghan GA, Papsidero LD, Valenzuela LA. Tissue distribution of an epithelial and tumor-associated antigen recognized by monoclonal antibody F36/22. Cancer Res 1983; 43: 4980–4988
   PubMed Web of Science ®Google Scholar
• Adams DJ, Hajj H, Edwards DP. Detection of a Mr 24,000 estrogen-related protein in human breast cancer by monoclonal antibodies. Cancer Res 1983; 43: 4297–4301
   PubMed Web of Science ®Google Scholar
• Yuan D, Hendler FJ, Vitetta ES. Characterization of a monoclonal antibody reactive with a subset of human breast tumors. J Natl Cancer Inst 1982; 68: 719–728
   PubMed Web of Science ®Google Scholar
• Soule HR, Linder E, Edgington TS. Membrane 126-kilodalton glycoprotein associated with human carcinomas identified by a hybridoma antibody to mammary carcinoma cells. Proc Natl Acad Sci (USA) 1983; 80: 1332–1336
   PubMed Web of Science ®Google Scholar
• Herzenberg LA, Herzenberg LA, Milstein C. Cell hybrids of myelomas with antibody forming cells and B-lymphocytes with T cells. Handbook of Experimental Immunology, DM Weir. Blackwell Scientific Publications, London 1978, Chapter 25.1–25.7
   Google Scholar
• Colcher D, Horan Hand P, Nuti M. A spectrum of monoclonal antibodies reactive with mammary tumor cells. Proc Natl Acad Sci (USA) 1981; 78: 3199–3202
   PubMed Web of Science ®Google Scholar
• Barnstable CJ, Bodmer WF, Brown G. Production of monoclonal antibodies to group A erythocytes, HLA and to human cell surface antigens—new tools for genetic analysis. Cell 1978; 14: 9–20
   PubMed Web of Science ®Google Scholar
• Kufe DW, Nadler L, Sargent L. Biological behavior of human breast carcinoma-associated antigens expressed during cellular proliferation. Cancer Res 1983; 43: 851–857
   PubMed Web of Science ®Google Scholar
• Colcher D, Horan Hand P, Nuti M. Differential binding to human mammary and nonmammary tumors of monoclonal antibodies reactive with carcinoembryonic antigen. Cancer Invest 1983; 1: 127–138
   PubMed Web of Science ®Google Scholar
• Schlom J, Greiner J, Horan Hand P. Human breast cancer markers as defined by monoclonal antibodies. Monoclonal Antibodies in Cancer, Cancer Markers III, S Sell, R Reisfeld. Humana Press, Clifton, NJ 1985; 247–277
   Google Scholar
• Foulds L. The experimental study of tumor progression: A review. Cancer Res 1954; 14: 327–329
   PubMed Web of Science ®Google Scholar
• Heppner G. Perspectives in cancer research—tumor heterogeneity. Cancer Res 1984; 44: 2259–2265
   PubMed Web of Science ®Google Scholar
• Miller FR, Heppner GH. Immunologic heterogeneity of tumor cell subpopulations from a single mouse mammary tumor. J Natl Cancer Inst 1979; 63: 1457–1463
   PubMedGoogle Scholar
• Neri A, Nicolson GL. Phenotypic drift of metastatic and cell-surface properties of mammary adenocarcinoma cell lines during growth in vitro. Int J Cancer 1981; 28: 731–738
   PubMed Web of Science ®Google Scholar
• Nowell PC. The clonal evolution of tumor cell population. Science 1976; 194: 23–28
   PubMed Web of Science ®Google Scholar
• Peterson JA, Ceriani RL, Blank EW. Comparison of rates of phenotypic variability in surface antigen expression in normal and cancerous human breast epithelial cells. Cancer Res 1983; 43: 4291–4296
   PubMed Web of Science ®Google Scholar
• Reading CL, Brunson KW, Tomanni M. Malignancies of metastatic murine lymphosarcoma cell lines and clones correlate with decreased cell surface display of RNA tumor virus envelope glycoprotein gp70. Proc Natl Acad Sci (USA) 1980; 77: 5943–5947
   PubMed Web of Science ®Google Scholar
• Schlag P, Schremi W. Heterogeneity in growth pattern and drug sensitivity of primary tumor and metastases in the human tumor colony-forming assay. Cancer Res 1982; 43: 4086–4089
   Google Scholar
• Horan Hand P, Colcher D, Salomon D. Spatial configuration of carcinoma cell populations influences the expression of a tumor associated glycoprotein. Cancer Res 1985; 45: 833–840
   PubMed Web of Science ®Google Scholar
• Horan Hand P, Nuti M, Colcher D. Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens. Cancer Res 1983; 43: 728–735
   PubMed Web of Science ®Google Scholar
• Schlom J, Colcher D, Horan Hand P. Antigenic heterogeneity, modulation and evolution in breast cancer lesions as defined by monoclonal antibodies. Understanding Breast Cancer: Clinical and Laboratory Concepts, M Rich, J. Hager, P Furmanski. Marcel Dekker, New York 1983; 169–213
   Google Scholar
• Greiner J, Tobi M, Fisher P. Differential responsiveness of cloned mammary carcinoma cell populations to human recombinant leukocyte (alpha) interferon medicated enhancement of tumor antigen expression. Int J Cancer 1985; 36: 159–166
   PubMed Web of Science ®Google Scholar
• Stramignoni D, Bowen R, Atkinson B. Differential reactivity of monoclonal antibodies with human colon adenocarcinomas and adenomas. Intl J Cancer 1982; 31: 543–552
   Web of Science ®Google Scholar
• Emerman JT, Burwen SJ, Pitelka DR. Substrate properties influencing ultrastructural differentiation of mammary epithelial cells in culture. Tissue Cell 1979; 11: 109–119
   PubMed Web of Science ®Google Scholar
• Gospodarowicz D, Gonzalez R, Fujii DK. Are factors originating from serum, plasma, or cultured cells involved in the growth-promoting effect of the extracellular matrix produced by cultured bovine corneal endothelial cells. J Cell Physiol 1983; 114: 191–202
   PubMed Web of Science ®Google Scholar
• Hyldahl L, Aver G. Permissive effect of the extracellular matrix on attachment and maintenance of human breast carcinoma cells in vitro. Cell Biol Int Rep 1982; 6: 989–996
   PubMedGoogle Scholar
• MacCallum DK, Lillie JH, Scaletta LJ. Bovine corneal endohelium in vitro. Elaboration and organization of a basement membrane. Exp Cell Res 1982; 139: 1–13
   PubMed Web of Science ®Google Scholar
• Montesano R, Mouron P, Armherdt M. Collagen matrix promotes endocrine cell monolayers into islet-like organoids. J Cell Biol 1983; 97: 935–939
   PubMed Web of Science ®Google Scholar
• Rheinwald G, Green H. Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes. Nature 1977; 265: 421–424
   PubMed Web of Science ®Google Scholar
• Salomon DS, Liotta LA, Kidwell WR. Differential response to growth factor by rat mammary epithelium plated on different collagen substrata in serum-free medium. Proc Natl Acad Sci (USA) 1981; 78: 382–386
   PubMed Web of Science ®Google Scholar
• Baron S, Dianzani F, Stanton GJ. The interferon system—A review to 1982. Texas Rep Biol Med 1982; 41: 1–715
   Google Scholar
• Balkwill FR. Interferons as cell-regulatory molecules. Cancer Immunol Immunother 1979; 7: 7–14
   Web of Science ®Google Scholar
• Grant S, Bhalla K, Weinstein IB. Differential effect of recombinant human leukocyte interferon on human leukemic and normal myeloid progenitor cells. Biochem Biophys Res Commun 1982; 108: 1048–1055
   PubMed Web of Science ®Google Scholar
• Grosser I, Toney MG. Antitumor effects of interferon. Biochem Biophys Acta 1978; 516: 231–247
   PubMedGoogle Scholar
• Isaacs A, Lindenmann J. Virus interference I. The interferon. Proc R Soc Lond (Biol) 1957; 147: 258–261
   PubMed Web of Science ®Google Scholar
• Herberman RB, Ortaldo JR, Bonnard G. Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity. Nature 1967; 277: 221–223
   Google Scholar
• Herberman RB, Ortaldo JR, Mantovani A. Effect of human recombinant interferon on cytoxic activity of natural killer (NK) and monocytes. Cell Immunol 1982; 67: 160–167
   PubMed Web of Science ®Google Scholar
• Lee SH, Kelly S, Chiu H. Stimulation of natural killer cell activity and inhibition of proliferation of various leukemic cells by purified human leukocyte interferon subtypes. Cancer Res 1982; 42: 1313–1316
   Google Scholar
• Imai K, Ng A-K, Glassy M. Differential effect of interferon on the expression of tumor-associated antigens and histocompatibility antigens on human melanoma cells: Relationship to susceptibility to immune lysis mediated by monoclonal antibodies. J Immunol 1981; 127: 505–508
   PubMed Web of Science ®Google Scholar
• Basham TY, Bourgeade MF, Creasey AA. Interferon increases HLA synthesis in melanoma cells: Interferon-resistant and sensitive cell lines. Proc Natl Acad Sci (USA) 1982; 79: 3265–3269
   PubMed Web of Science ®Google Scholar
• Dolei A, Capobianchi MR, Ameglio F. Human interferon-gamma enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively than interferon-alpha and interferon-beta. Infect Immun 1983; 40: 172–176
   PubMed Web of Science ®Google Scholar
• Fellous M, Kamoun M, Gresser I. Enhanced expression of HLA antigens and B2-microglobulin on interferon-treated human lymphoid cells. Eur J Immunol 1979; 9: 446–449
   PubMed Web of Science ®Google Scholar
• Liao S-K, Kwong PC, Khosravi M. Enhanced expression of melanoma-associated antigens and B2-microglobulin on cultured cells by interferon. J Natl Cancer Inst 1982; 68: 19–25
   PubMed Web of Science ®Google Scholar
• Attallah AM, Needy CF, Noguchi PD. Enhancement of carcinoembryonic antigen expression by interferon. Int J Cancer 1979; 24: 49–52
   PubMed Web of Science ®Google Scholar
• Lee SH, Chiu H, Rinderknecht E. Importance of treatment regimen of interferon as an antitumor agent. Cancer Res 1983; 43: 4172–4175
   PubMed Web of Science ®Google Scholar
• Gutterman JU, Fine S, Quesada J. Recombinant leukocyte A interferon: Pharmacokinetics, single-dose tolerance and biologic effects in cancer patients. Ann Int Med 1982; 96: 549–556
   PubMed Web of Science ®Google Scholar
• Wallach D, Fellous M, Revel M. Preferential effect of gamma-interferon on the synthesis of HLA antigens and their mRNAs. Nature 1982; 299: 833–836
   PubMed Web of Science ®Google Scholar
• Ng A-K, Giacomini P, Kantor RS. Recombinant human interferons alter the expression and shedding of tumor-associated antigens and susceptibility to immune lysis of human melanoma cells. Proc Am Assoc Cancer Res 1983; 24: 196
   Web of Science ®Google Scholar
• Greiner JW, Horan Hand P, Noguchi P. Enhanced expression of tumor-associated antigens on human breast and colon tumor cells after recombinant human leukocyte alpha-interferon treatment. Cancer Res 1984; 44: 3208–3214
   PubMed Web of Science ®Google Scholar
• Greiner JW, Horan Hand P, Noguchi P. Detection and enhancement by recombinant interferon of carcinoma cell surface antigens using monoclonal antibodies. Cancer Cells, 1/Transformed Phenotype, AJ Levine, OF Vande Woude, WC Topp, JD Watson. Cold Spring Harbor Press, New York 1984; Vol. n: 285–291
   Google Scholar
• Pestka S. The human interferons—purification and sequence to cloning and expression in bacteria: Before, between and beyond. Arch Biochem Biophys 1983; 221: 1–37
   PubMed Web of Science ®Google Scholar
• Pestka S, Kelder B, Rehberg E. The specific molecular activities of interferons differ for antiviral, antiproliferative and natural killer cell activities. The Biology of the Interferon System, E DeMaeyer, H Schellekens. Elsevier, Amsterdam 1983; 535–549
   Google Scholar